Skip to main content

Advertisement

Table 3 Site of first progression (n = 14)

From: Phase II trial of selective internal radiation therapy and systemic chemotherapy for liver-predominant metastases from pancreatic adenocarcinoma

Location of first progression Patients
Number Percentage
Documented progression on CT
 Liver 2 20
 Lung 2 13
 Lymph node 1 7
 Peritoneum 1 7
 Pleural effusion 1 7
No progression documented
 Clinical deterioration 3 20
 Death without progression 2 13
 Withdrawn due to adverse events 2 13